# Semax + Selank blend

Source: https://aminodesk.com/library/semax-selank
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

This blend combines Semax and Selank in one product. It is sold for focus with less anxiety. We found no trial of the two together, and a mixed product falls outside the 2026 compounding policy.

- **Legal lane:** outside the October 2026 policy. Not FDA-approved.
- **Evidence grade:** D for the combination
- **What is in it:** Semax and Selank
- **Established human dose:** none

## What it is

A premixed product sold by peptide suppliers and some clinics. The ingredients:

- **[Semax](https://aminodesk.com/library/semax):** one of the six peptides in the October 2026 policy; its human evidence is small, mostly Russian studies.
- **[Selank](https://aminodesk.com/library/selank):** a Russian anti-anxiety peptide; not one of the six policy peptides.

## What the evidence shows

We found no trial of this combination. The evidence that exists applies to each ingredient studied on its own, and each ingredient's page has its grade and what was shown.

The case for mixing them is that they act by different routes, so the effects should add up. That is a hypothesis. Nobody has measured whether the mixture does better than its parts, or whether it is as safe.

## Legal status

In October 2026, HHS issued an interim policy allowing licensed pharmacies to compound six peptides on prescription: BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax. One condition is that the compounded product contains a single active ingredient from that list. Law firms that analyzed the policy concluded that products with more than one active ingredient fall outside it.

This blend is outside the policy on two counts: it holds more than one active ingredient, and Selank is not one of the six peptides.

## Reported dosing

**No dose has been established for this blend.**

No human trial has tested it. The mixing tables and schedules published by sellers are their own arithmetic. Where we can report dosing for an individual ingredient, it is on that compound's own page, with the source shown.

## Safety

- If you improve, you cannot tell which ingredient did it. If you react, you cannot tell which one caused it.
- The ratio is fixed by the seller. You cannot adjust one ingredient without moving the other.
- No safety or absorption work exists on the mixture.
- A product made outside the pharmacy system has no verified contents or sterility.

## Common questions

### What is in this blend?

Semax and Selank.

### Has this blend been tested in people?

We found no human trial of the combination.

### Is this blend legal?

Not under the October 2026 policy. It holds two active ingredients, and Selank is not one of the six peptides the policy covers.

## Sources

- [HHS: 503A peptide enforcement discretion policy, including the single-ingredient condition](https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf)
- [McDermott Will & Emery: the conditions exclude multiple-ingredient compounded products](https://www.mcdermottlaw.com/insights/peptides-first-paperwork-later-hhs-clears-six-for-compounding-ahead-of-bulks-list-rulemaking/)
- [Superpower: Semax and Selank, quality of the human evidence](https://superpower.com/guides/semax)

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
